BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
SubscribeLog In More Log in via InstitutionLog in via OpenAthens Log in using your username and password Basket Search More Advanced search Latest contentCurrent issueArchiveAuthorsAboutPodcasts Advanced search CloseMore Main menu Latest contentCurrent issueArchiveAuthorsAboutPodcasts SubscribeLog in More Log in via InstitutionLog in via OpenAthens Log in using your username and password BMJ Journals You are hereHomeOnline FirstBCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase... Читать дальше...